Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
2 CUHK - The Chinese University of Hong Kong
3 Unibas - Université de Bâle = University of Basel = Basel Universität
4 University Hospital Basel [Basel]
5 GCNI - Gerald Choa Neuroscience Institute
6 Inselspital - Bern University Hospital [Berne]
7 UNIBE - Universität Bern = University of Bern = Université de Berne
8 UCL - University College London [UCL]
9 Department of Brain Repair and Rehabilitation - Stroke Research Group [London, UK]
10 UCL Queen Square Institute of Neurology
11 NZBRI - New Zealand Brain Research Institute
12 KUGH - Korea University Guro Hospital [ Seoul, Republic of Korea]
13 Asan Medical Center [Seoul]
14 UUCM - University of Ulsan- College of Medicine [Ulsan, Republic of Korea]
15 N3C - Suita - National Cerebral and Cardiovascular Center [Osaka, Japon]
16 Hôpital Lariboisière-Fernand-Widal [APHP]
17 GHU-PPN - FHU NeuroVasc [CH Sainte-Anne]
18 NeuroDiderot (UMR_S_1141 / U1141) - Maladies neurodéveloppementales et neurovasculaires
19 University of Heidelberg, Medical Faculty
20 University Hospital Mannheim | Universitätsmedizin Mannheim
21 HKU - The University of Hong Kong
22 Hospital de la Santa Creu i Sant Pau
23 Vall Hebron Research Institute - Biomedical Research Group in Gynecology [Barcelona, Spain]
24 KCGH - Kushiro City General Hospital [Kushiro, Japon]
25 Massachusetts General Hospital [Boston]
26 HMS - Harvard Medical School [Boston]
27 Heidelberg University Hospital [Heidelberg]
28 Yonsei University
29 EWHA - EWHA Womans University
30 VIB-KU Leuven | CBD - VIB-KU Leuven Center for Brain & Disease Research
31 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
32 UZ Leuven - Universitair Ziekenhuis Leuven = University Hospital of Leuven = Hopital universitaire de Louvain
33 Medical University of Graz = Medizinische Universität Graz
34 Antalya Education and Research Hospital [Antalya, Turkey]
35 University of Health Sciences [Istanbul, Turkey]
36 Şişli Hamidiye Etfal Training and Research Hospital [Istanbul, Turkey]
37 Tel Aviv Sourasky Medical Center [Tel Aviv]
38 TAU - Tel Aviv University
39 Saga University [Japon]
40 St. Mary's Hospital [Fukuoka, Japan]
41 Hotchkiss Brain Institute [Calgary]
42 University of Calgary
43 UMCU - University Medical Center [Utrecht]
44 Universiteit Utrecht / Utrecht University [Utrecht]
45 CCBS - Centre For Clinical Brain Sciences - Neuroimaging Sciences [Edinburgh, U.K.]
46 The University of Edinburgh
47 NHNN - National Hospital for Neurology and Neurosurgery
48 University of Liverpool
49 LJMU - Liverpool John Moores University
50 LH&CH - Liverpool Heart and Chest Hospital NHS Trust [UK]
51 IPNP - U1266 Inserm - Institut de psychiatrie et neurosciences de Paris
52 GHU Paris Psychiatrie et Neurosciences - Groupe hospitalier universitaire Paris psychiatrie & neurosciences [Paris]
53 Centre Hospitalier Sainte-Anne [Paris]
54 Monash University [Melbourne]
55 University Hospital Wuerzburg / Universitätsklinikum Würzburg
56 University of Aberdeen
57 TUH - Tallaght University Hospital [Dublin, Ireland]
58 RCSI - Royal College of Surgeons in Ireland
59 HB - Hôpital de Beaumont [Dublin, Ireland]
60 Erasmus MC - Erasmus University Medical Center [Rotterdam]
61 Amsterdam UMC - Amsterdam University Medical Centers
62 UniFI - Università degli Studi di Firenze = University of Florence = Université de Florence
63 UCLH - University College London Hospitals NHS Foundation Trust [London, UK]
64 RadboudUMC - Radboud University Medical Center [Nijmegen]
65 Troubles cognitifs vasculaires et dégénératifs
66 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
67 MUMC - Maastricht University Medical Centre
68 CARIM - Cardiovascular Research Institute Maastricht
69 Zhejiang University [Hangzhou, China]
70 NUS - National University of Singapore
71 Yong Loo Lin School of Medicine [Singapore]
72 LilNCog - Lille Neurosciences & Cognition - U 1172
73 NTU | LKCMedicine - Lee Kong Chian School of Medicine [Nanyang Technological University]
74 NHSL - NHS Lothian [Edinburgh, Scotland]
75 UCD - University College Dublin [Dublin]
76 OLVG Hospital
77 Kansai University
78 Istanbul Arel University
79 University of Melbourne
80 Imperial College London
81 SNUCM - Seoul National University College of Medicine [Séoul, Corée du Sud]
82 Hirnschlagzentrum - Stroke center [Hôpital de Bâle]
- Fonction : Auteur
- PersonId : 1259709
- ORCID : 0000-0002-3489-3201
- Fonction : Auteur
- PersonId : 1259710
- ORCID : 0000-0002-4362-2497
- Fonction : Auteur
- PersonId : 1259711
- ORCID : 0000-0002-9475-2208
- Fonction : Auteur
- PersonId : 808764
- ORCID : 0000-0003-3890-3849
- Fonction : Auteur
- Fonction : Auteur
- PersonId : 1259712
- ORCID : 0000-0002-6758-4026
- Fonction : Auteur
- PersonId : 1163170
- ORCID : 0000-0001-8436-6074
- IdRef : 060577304
- Fonction : Auteur
- PersonId : 1248659
- ORCID : 0000-0002-6065-6576
- Fonction : Auteur
- Fonction : Auteur
- PersonId : 1259714
- ORCID : 0000-0001-5800-116X
- Fonction : Auteur
- Fonction : Auteur
- PersonId : 1259715
- ORCID : 0000-0001-7480-1482
- Fonction : Auteur
- PersonId : 1259716
- ORCID : 0000-0002-4815-2834
- Fonction : Auteur
- PersonId : 1259717
- ORCID : 0000-0003-3577-4527
- Fonction : Auteur
- PersonId : 1248986
- ORCID : 0000-0003-3916-6422
- Fonction : Auteur
- PersonId : 1259718
- ORCID : 0000-0001-9244-4298
- Fonction : Auteur
- PersonId : 1259719
- ORCID : 0000-0002-9812-6642
- Fonction : Auteur
- PersonId : 1163169
- ORCID : 0000-0001-7797-2236
- IdRef : 117664359
- Fonction : Auteur
- PersonId : 1259721
- ORCID : 0000-0002-8346-9845
- Fonction : Auteur
- PersonId : 1259722
- ORCID : 0000-0002-4751-3538
- Fonction : Auteur
- PersonId : 1259723
- ORCID : 0000-0001-9229-8649
Résumé
Objectives: Cerebral microbleeds are associated with the risks of ischemic stroke and intracranial hemorrhage, causing clinical dilemmas for antithrombotic treatment decisions. We aimed to evaluate the risks of intracranial hemorrhage and ischemic stroke associated with microbleeds in patients with atrial fibrillation treated with vitamin K antagonists, direct oral anticoagulants, antiplatelets, and combination therapy (i.e. concurrent oral anticoagulant and antiplatelet). Methods: We included patients with documented atrial fibrillation from the pooled individual patient data analysis by the Microbleeds International Collaborative Network. Risks of subsequent intracranial hemorrhage and ischemic stroke were compared between patients with and without microbleeds, stratified by antithrombotic use. Results: A total of 7,839 patients were included. The presence of microbleeds was associated with an increased relative risk of intracranial hemorrhage (adjusted hazard ratio [aHR] = 2.74, 95% confidence interval = 1.76-4.26) and ischemic stroke (aHR = 1.29, 95% confidence interval = 1.04-1.59). For the entire cohort, the absolute incidence of ischemic stroke was higher than intracranial hemorrhage regardless of microbleed burden. However, for the subgroup of patients taking combination of anticoagulant and antiplatelet therapy, the absolute risk of intracranial hemorrhage exceeded that of ischemic stroke in those with 2 to 4 microbleeds (25 vs 12 per 1,000 patient-years) and ≥ 11 microbleeds (94 vs 48 per 1,000 patient-years). Interpretation: Patients with atrial fibrillation and high burden of microbleeds receiving combination therapy have a tendency of higher rate of intracranial hemorrhage than ischemic stroke, with potential for net harm. Further studies are needed to help optimize stroke preventive strategies in this high-risk group.
Domaines
| Origine | Publication financée par une institution |
|---|---|
| Licence |